Sugi Predict

Sugi Predict / Compounds / SCHEMBL29415985

SCHEMBL29415985

SCHEMBL29415985

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H](N)Cc1c[nH]c2ccccc12)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ KISS1R Q969F8 19/20 0.64
▸ ECE1 P42892 1/20 0.58
▸ GLP1R P43220 1/20 0.58
▸ MUS81 Q96NY9 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29416056 0.93 KISS1R (0.62) KISS1RECE1GLP1RMUS81
SCHEMBL30956236 0.91 GHSR (0.63) KISS1R
SCHEMBL30130556 0.91 KISS1R (0.65) KISS1RECE1GLP1RMUS81
SCHEMBL31188709 0.90 KISS1R (0.64) KISS1R
SCHEMBL31622725 0.90 GLP1R (0.57) KISS1RECE1GLP1RMUS81
SCHEMBL30533150 0.90 EDNRA (0.64) KISS1RECE1GLP1RMUS81
SCHEMBL30130528 0.90 NPBWR1 (0.62) KISS1RECE1GLP1RMUS81
SCHEMBL30906400 0.89 GLP1R (0.69) ECE1GLP1RMUS81
SCHEMBL30093029 0.88 EDNRA (0.57) KISS1R
SCHEMBL30401709 0.88 KISS1R (0.62) KISS1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110381984-B Compositions and methods for improving sexual function 尼莫克斯股份有限公司 2023-11-28 — — CN disclosed
EP-4275688-A2 METHOD OF AMELIORATING OR PREVENTING THE WORSENING OR THE PROGRESSION OF SYMPTOMS OF BPH Nymox Corporation (BS) 2023-11-15 — — EP disclosed
CN-116785403-A Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-09-22 — — CN disclosed
CN-109310732-B Neurofilament peptides for preventing or slowing the progression of prostate cancer 尼莫克斯股份有限公司 2023-07-21 — — CN disclosed
US-11628202-B2 Methods of reducing the need for surgery in patients suffering from benign prostatic hyperplasia NYMOX CORPORATION (CA) 2023-04-18 — — US disclosed
CN-114099636-A Method of treating a condition requiring cell destruction or removal using peptides derived from neurofilament proteins 尼莫克斯制药公司 2022-03-01 — — CN disclosed
Send feedback